Educational Resources
The Point-of-Care Diagnostics Accelerator builds on the expertise within the Lab-to-Market network and focuses on the development of go-to-market strategies for the PORTENT cohort. Find out more!
PORTENT advances promising Point of Care technologies through:
Technology Development | Human Validation | User and Developer Training and Rotations | Commercialization
PORTENT translates breakthrough point-of-care diagnostics into rapid, affordable tests that reduce the burden of chronic disease, curb infectious threats, and strengthen prevention efforts across the United States. By integrating technology development with clinical validation, training, and lab-to-market programs, PORTENT accelerates earlier detection of conditions – from diabetes, heart disease to emerging infections – so providers can intervene sooner, patients stay healthier, and health care costs decline.
OUR GLOBAL PRESENCE
The PORTENT Center is unique as it:
Focuses on primary health care globally
Addresses the needs of the most vulnerable in the US and internationally
Enables validation of diagnostic technologies on a global range of populations and with a unique set of users
Develops expertise and strengthens capacity worldwide to have the most impact even beyond the center
One-of-a-kind international network of clinical, training, and device development facilities
Unique worldwide expertise in Point of Care diagnostics, their application and commercialization
Integrated clinical core and validation facilities across four continents: North America (United States), Africa (Uganda), South America (Ecuador) and Asia (India)
APPROACH & RESOURCES
NEWS & EVENTS
Julia Finkelstein awarded the ASNF-NNF Henrik Dam Award for Scientific Discovery in Nutrition
May 6, 2025
The American Society for Nutrition Foundation (ASNF) and the Novo Nordisk Foundation (NNF) has awarded Julia Finkelstein, Associate Professor in the Division of Nutritional Sciences, with the inaugural ASN-NNF Henrik Dam Award for Scientific Discovery in Nutrition….READ MORE
Cornell researchers awarded grant to advance tuberculosis diagnostics
December 1, 2025
A project led by Cornell’s Center for Point of Care Technologies for Nutrition, Infection and Cancer (PORTENT) to develop a low-cost, battery-powered device for sample preparation in tuberculosis (TB) testing in areas with limited lab access and infrastructure, has received a $250,000 grant from the Gates Foundation….READ MORE
OUR PARTNERS
